FOLH1 and prostate carcinoma: According to the FDA approval, [68Ga]Ga-PSMA-11 is indicated for patients with suspected prostate cancer metastasis who are potentially curable by surgery or radiation therapy, as well as for patients with suspected prostate cancer recurrence.